Literature DB >> 17908692

The advantages of being locked. Assessing the cleavage of short and long RNAs by locked nucleic acid-containing 8-17 deoxyribozymes.

Stefano Donini1, Marcello Clerici, Jesper Wengel, Birte Vester, Alessio Peracchi.   

Abstract

RNA-cleaving deoxyribozymes can be used for the sequence-specific knockdown of mRNAs. It was previously shown that activity of these deoxyribozymes is enhanced when their substrate-binding arms include some locked nucleic acid (LNA) residues, but the mechanistic basis of this enhancement was not explored. Here we dissected the kinetics and thermodynamics underlying the reaction of LNA-containing 8-17 deoxyribozymes. Four 8-17 constructs were designed to target sequences within the E6 mRNA from human papillomavirus type 16. When one of these deoxyribozymes (DNAzymes) and the corresponding LNA-armed enzyme (LNAzyme) were tested against a minimal RNA substrate, they showed similar rates of substrate binding and similar rates of intramolecular cleavage, but the LNAzyme released its substrate more slowly. The superior thermodynamic stability of the LNAzyme-substrate complex led to improved performances in reactions carried out at low catalyst concentrations. The four DNAzymes and the corresponding LNAzymes were then tested against extended E6 transcripts (>500 nucleotides long). With these structured substrates, the LNAzymes retained full activity, whereas the DNAzymes cleaved extremely poorly, unless they were allowed to pre-anneal to their targets. These results imply that LNAzymes can easily overcome the kinetic barrier represented by local RNA structure and bind to folded targets with a faster association rate as compared with DNAzymes. Such faster annealing to structured targets can be explained by a model whereby LNA monomers favor the initial hybridization to short stretches of unpaired residues ("nucleation"), which precedes disruption of the local mRNA structure and completion of the binding process.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17908692     DOI: 10.1074/jbc.M706993200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Conformationally restricted nucleotides as a probe of structure-function relationships in RNA.

Authors:  Kristine R Julien; Minako Sumita; Po-Han Chen; Ite A Laird-Offringa; Charles G Hoogstraten
Journal:  RNA       Date:  2008-07-02       Impact factor: 4.942

2.  A modular XNAzyme cleaves long, structured RNAs under physiological conditions and enables allele-specific gene silencing.

Authors:  Alexander I Taylor; Christopher J K Wan; Maria J Donde; Sew-Yeu Peak-Chew; Philipp Holliger
Journal:  Nat Chem       Date:  2022-09-05       Impact factor: 24.274

3.  Depletion of unwanted nucleic acid templates by selective cleavage: LNAzymes, catalytically active oligonucleotides containing locked nucleic acids, open a new window for detecting rare microbial community members.

Authors:  Jan Dolinsek; Christiane Dorninger; Ilias Lagkouvardos; Michael Wagner; Holger Daims
Journal:  Appl Environ Microbiol       Date:  2012-12-21       Impact factor: 4.792

4.  Locked and unlocked nucleosides in functional nucleic acids.

Authors:  Holger Doessing; Birte Vester
Journal:  Molecules       Date:  2011-05-27       Impact factor: 4.411

5.  One-step isothermal RNA detection with LNA-modified MNAzymes chaperoned by cationic copolymer.

Authors:  Orakan Hanpanich; Ken Saito; Naohiko Shimada; Atsushi Maruyama
Journal:  Biosens Bioelectron       Date:  2020-06-12       Impact factor: 10.618

6.  Standardization of an LNA-based TaqMan assay qPCR analysis for Aspiculuris tetraptera DNA in mouse faeces.

Authors:  Keishiro Isayama; Kenji Watanabe; Mariko Okamoto; Tomoaki Murata; Yoichi Mizukami
Journal:  BMC Microbiol       Date:  2020-12-07       Impact factor: 3.605

7.  Targeting non-coding RNA family members with artificial endonuclease XNAzymes.

Authors:  Maria J Donde; Adam M Rochussen; Saksham Kapoor; Alexander I Taylor
Journal:  Commun Biol       Date:  2022-09-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.